Gide advises the Banks in Successful Oversubscribed Abivax €130 Million Cross-Over Financing at Market Price with Top-Tier U.S. and European Biotech Investors
Gide has advised the financial advisors SVB Securities, LifeSci Capital et Bryan, Garnier & Co in connection with the successful pricing of an oversubscribed Abivax €130 million financing with high-quality U.S. and European biotech specialist investors, by way of a reserved capital increase. This is the largest private placement of a biotech company listed only on Euronext Paris.